Piper Sandler analyst Edward Tenthoff lowered the firm’s price target on Omega Therapeutics (OMGA) to $4 from $9 and keeps an Overweight ...
Raymond James downgraded Omega Therapeutics (OMGA) to Market Perform from Outperform. Published first on TheFly – the ultimate source ...